Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Low-dose of Fuganlin Oral Liquid
High-dose of Fuganlin Oral Liquid
Locations
1
China
Guangdong Provincial Hospital of Traditional Chinese Medicine
Guangzhou, Guangdong, China
Start Date
August 1, 2013
Primary Completion Date
May 1, 2017
Completion Date
May 1, 2017
Last Updated
May 22, 2017
NCT02622659
NCT02539277
NCT01814293
Lead Sponsor
Guangzhou Yipinhong Pharmaceutical CO.,LTD
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions